Niche Expertise ACD specializes in cell-based assay systems with deep expertise in kinases, GPCRs, ion channels and transcription factors, offering opportunities to upsell contract research, custom assay development, and tool validation for oncology, immunology and neurobiology clients.

Contract Research Upsell Leverage their strong CRO capability to position additional services such as gene disruption in stem cells, assay platform creation, and bespoke screening campaigns for clients seeking integrated discovery solutions.

Small Team agility With a lean 2-10 employee base, target personalized outreach to startups and mid-sized biotechs seeking flexible partnerships, pilot projects, and rapid iteration cycles in assay development.

Global Access ACD serves a global clientele; emphasize scalable collaboration potential, remote project management, and multi-region support for contract services to attract international biotech customers.

Emerging funding signals As a younger company with modest current revenue, highlight cost-effective pilot programs, milestone-based pricing, and proof-of-concept studies to convert interest into long-term contracts as customers invest in assay technologies.